Barbour Group - Research
Our current research projects focus on:
- Whole genome sequencing of oesophageal adenocarcinoma
- Intratumour heterogeneity
- Genomic evolution
- Circulating biomarkers for precision medicine
- Neoantigens and immune response
- Radiomics
- Whole exome sequencing of melanoma
- Intratumour heterogeneity
- Circulating biomarkers for precision medicine
- Radiomics
- Clinical Trials
- MASTERPLAN for pancreatic cancer
Student projects
- Use circulating tumour DNA (ctDNA) from stage III/IV melanoma patients to confirm the feasibility of using ‘liquid biopsy’ as a non-invasive test for assessing tumour burden. This will be used as a biomarker for prognostication and monitoring of treatment response.